Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03167125 · ClinicalTrials.gov registry record · NA
Participatory Research to Advance Colon Cancer Prevention
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 27,580
- Enrollment target
NCT03167125: Completed NA study, sponsored by Kaiser Permanente.
NCT03167125 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 27,580 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1866% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03167125, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 27,580 participants
- Enrollment target
Study Summary
The overall goal of this study is to test strategies to raise rates of colorectal cancer screening among the Latino population in a federally qualified health center that operates multiple clinics. This intervention study will test automated and live prompts to a direct-mail fecal testing program in two phases. In Phase I (Years 01 - 02), the investigators will tailor and define intervention components using a community-based participatory research approach called boot camp translation (BCT). The ultimate design of the intervention will be defined by patient and provider feedback from BCT. The investigators will then conduct a three-arm patient-randomized comparative effectiveness trial in two pilot clinics to compare 1) automated prompts (i.e., automated phone calls, text messages) to alert and remind patients to complete screening, 2) live prompts (i.e., live phone calls), and 3) a combination approach of automated plus live prompts. In Phase II (Years 03 - 05), the investigators will spread and test the spread of the adapted intervention to additional clinics within the partnering health center using a two-arm main trial. Both phases will be guided by an advisory group of clinicians, researchers, policy makers, and patients.
Primary Outcome
Fecal testing completion
Interventions
- OTHER Automated Prompts
- OTHER Automated Plus Live Prompts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27,580 participants |
| Start Date | 2017-09-05 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT03167125 record still lists
NCT03167125 is an interventional study that assigns participants to a tested intervention. Its 27,580 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1866% higher).
The record links to 0 conditions, and to 2 interventions - of which Automated Prompts is the first listed.
NCT03167125 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03167125 about?
NCT03167125 is a clinical study titled "Participatory Research to Advance Colon Cancer Prevention". The overall goal of this study is to test strategies to raise rates of colorectal cancer screening among the Latino population in a federally qualified health center that operates multiple clinics. This intervention study will test automated and live prompts to a direct-mail fecal testing program in...
What is the current status of trial NCT03167125?
This trial is currently completed. It is a NA study. The enrollment target is 27,580 participants. The study started on 2017-09-05. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03167125?
The interventions under investigation include: Automated Prompts (OTHER), Automated Plus Live Prompts (OTHER).
Who is sponsoring clinical trial NCT03167125?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03167125's enrollment target sits among peer trials
27,580 9th of 2000 higher than 1,992 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04494945 · 27,500 participants · NA
Identifying and Caring for Individuals With Inherited Cancer Syndrome
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI